Delivery Order SPE2DB22D3016-SPE2DB25FBHE1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,207.91 to AmerisourceBergen Drug Corp on September 4, 2025, for Rectiv 0.4% Ointment in 30-gram units. This is a firm fixed price delivery order with no set-aside designation, with an ultimate completion date of September 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,776.34 firm fixed-price delivery order is for the supply of "RECTIV 0.4% OINTMENT 30GM" medical products. The contract has an ultimate completion date of March 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,373.43 firm fixed price delivery order is for the supply of RECTIV 0.4% ointment, a pharmaceutical product. The contract has an ultimate completion date of March 24, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,062.14 firm fixed-price delivery order is for the supply of 4566134271 - RECTIV 0.4% OINTMENT 30GM, with a completion date of October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,528.97, is for the delivery of RECTIV 0.4% ointment in 30-gram quantities. The contract is a firm fixed-price, non-set-aside award with a period of performance through May 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
- This federal contract award is for the delivery of RECTIV 0.4% OINTMENT 30GM to the Defense Logistics Agency (DLA). The contract, valued at $4,692.01, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,653.00 firm fixed-price contract is for the supply of 4568232833 RECTIV 0.4% OINTMENT 30GM, a pharmaceutical product. The contract has an ultimate completion date of May 14, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,236.97 firm fixed-price delivery order is for the supply of "RECTIV 0.4% OINTMENT 30GM" medical products. The contract has an ultimate completion date of June 12, 2024 and was awarded on June 11, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,287.63 firm fixed-price delivery order is for the supply of RECTIV 0.4% OINTMENT 30GM, a medical product. The award has an ultimate completion date of June 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded a $10,120.82 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide RECTIV 0.4% OINTMENT 30GM. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBHE1Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Rectiv 0.4% Ointment in 30-gram quantities, with a ceiling value of $2,518.06 and an ultimate completion date of September 5, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order exemplifies the Defense Logistics Agency's reliance on AmerisourceBergen as a critical pharmaceutical distributor supporting military and federal healthcare systems worldwide. As a major healthcare solutions provider, AmerisourceBergen maintains a comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's ability to fulfill such delivery orders through open competition demonstrates its established capability to meet rigorous federal procurement standards and support the Defense Health Agency and other government healthcare customers through flexible contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/4/25 |